z-logo
open-access-imgOpen Access
ASSOCIATION OF SERUM TNF- A WITH INSULIN RESISTANCE IN PRE-DIABETES AND TYPE 2 DIABETES MELLITUS
Author(s) -
Priyanka Gupta,
P J Hisalkar,
Neerja Mallick
Publication year - 2021
Publication title -
international journal of advanced research
Language(s) - English
Resource type - Journals
ISSN - 2320-5407
DOI - 10.21474/ijar01/13699
Subject(s) - insulin resistance , diabetes mellitus , medicine , tumor necrosis factor alpha , type 2 diabetes , endocrinology , type 2 diabetes mellitus , pathogenesis , insulin , inflammation , necrosis
Background- First adipocyte derived biomarker is tumor necrosis factor alpha which connect the link between inflammation and diabetes. It expresses m-RNA which is contributing to the development of insulin resistance. However, the relationship between tumor necrosis factor alpha, pre-diabetes and Type2diabetes mellitus is still contradictory and restricted. Material & Methods: This study was hospital based analytical cross-sectional study. Total 900 subjects were distributed into three groups (300 pre-diabetic subjects, 300 type 2 diabetic subjects and 300 healthy subjects) as per ADA criteria. The biochemical parameters as Fasting Blood Glucose, 2-hr glucose (after 75 gm oral glucose intake), HbA1c and fasting insulin were analyzed. HOMA-IR was used to calculate insulin resistance mathematically. Anthropometric measurements were done. Tumor necrosis factor alpha was done by ELISA method. Results: Tumor necrosis factor alpha concentration was significantly increased in patients with type 2 diabetes mellitus and pre-diabetes in comparison to the control group at p value < 0.001 and showed a positive correlation with HOMA -IR. In conclusion, our findings suggested that systemic inflammation has an important role in the pathogenesis of pre diabetic condition. There is a progressive raises value of tumor necrosis factor alpha in pre diabetic and diabetic patients. Therefore, inflammation reflects the severity of the disease and signifies the presence of ongoing disease process.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here